ABIOMED INC (ABMD) Stock Analyst Ratings
NASDAQ:ABMD - Nasdaq - US0036541003 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 70% to ABMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 375.36. This target is -1.49% below the current price.
ABMD was analyzed by 16 analysts. The buy percentage consensus is at 70. So analysts seem to be have mildly positive about ABMD.
In the previous month the buy percentage consensus was at a similar level.
ABMD was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-02 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2022-11-02 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2022-11-01 | William Blair | Downgrade | Outperform -> Market Perform |
| 2022-11-01 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022-10-13 | Mizuho | Initiate | Buy |
| 2022-10-10 | Piper Sandler | Maintains | Overweight |
| 2022-07-21 | Deutsche Bank | Maintains | Buy |
| 2022-07-15 | Morgan Stanley | Maintains | Underweight |
| 2022-02-04 | SVB Leerink | Maintains | Market Perform |
| 2022-02-04 | Morgan Stanley | Maintains | Underweight |
| 2022-01-07 | Morgan Stanley | Maintains | Underweight |
| 2021-08-06 | SVB Leerink | Maintains | Market Perform |
| 2021-07-20 | SVB Leerink | Maintains | Market Perform |
| 2021-06-18 | Deutsche Bank | Initiate | Buy |